Chapter 1. Medical Informatics for Auto-immune Diseases Market – Scope & Methodology
1.1    Market Segmentation
1.2    Scope, Assumptions & Limitations
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources 
Chapter 2. Medical Informatics for Auto-immune Diseases Market – Executive Summary
2.1    Market Size & Forecast – (2024 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
           2.2.1    Demand Side
           2.2.2    Supply Side
2.3    Attractive Investment Propositions
2.4    COVID-19 Impact Analysis 
Chapter 3. Medical Informatics for Auto-immune Diseases Market – Competition Scenario
3.1    Market Share Analysis & Company Benchmarking
3.2    Competitive Strategy & Development Scenario
3.3    Competitive Pricing Analysis
3.4    Supplier-Distributor Analysis 
Chapter 4. Medical Informatics for Auto-immune Diseases Market - Entry Scenario
4.1    Regulatory Scenario
4.2    Case Studies – Key Start-ups
4.3    Customer Analysis
4.4    PESTLE Analysis
4.5    Porters Five Force Model
           4.5.1    Bargaining Power of Suppliers
           4.5.2    Bargaining Powers of Customers
           4.5.3    Threat of New Entrants
           4.5.4    Rivalry among Existing Players
           4.5.5    Threat of Substitutes 
Chapter 5. Medical Informatics for Auto-immune Diseases Market – Landscape
5.1    Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Medical Informatics for Auto-immune Diseases Market – By Type
6.1    Introduction/Key Findings   
6.2    Hospital Information Systems
6.3    Electronic Health Record
6.4    Electronic Medical Record
6.5    Real-time Healthcare
6.6    Patient Engagement Solutions
6.7    Population Health Management
6.8    Others
6.9    Pharmacy Information Systems
6.10    Prescription Management
6.11    Automated Dispensing Systems
6.12    Inventory Management
6.13    Others
6.14    Laboratory Information Systems
6.15    Medical Imaging Information Systems
6.16    Radiology Information Systems
6.17    Monitoring Analysis Software
6.18    Picture Archiving and Communication Systems
6.19    Others
6.20    Health Insurance Information Systems
6.21    Y-O-Y Growth trend Analysis By Type
6.22    Absolute $ Opportunity Analysis By Type, 2024-2030 
Chapter 7. Medical Informatics for Auto-immune Diseases Market – By End-Users
7.1    Introduction/Key Findings   
7.2    Hospitals and Clinics
7.3    Pharmaceutical and Biotechnology Companies
7.4    Research Institutes and Laboratories
7.5    Others
7.6    Y-O-Y Growth  trend Analysis By End-Users
7.7    Absolute $ Opportunity Analysis By End-Users, 2024-2030  
Chapter 8. Medical Informatics for Auto-immune Diseases Market , By Geography – Market Size, Forecast, Trends & Insights
8.1    North America
           8.1.1    By Country
                      8.1.1.1    U.S.A.
                      8.1.1.2    Canada
                      8.1.1.3    Mexico
           8.1.2    By Type
           8.1.3    By End-Users
           8.1.4    Countries & Segments - Market Attractiveness Analysis
8.2    Europe
           8.2.1    By Country
                      8.2.1.1    U.K
                      8.2.1.2    Germany
                      8.2.1.3    France
                      8.2.1.4    Italy
                      8.2.1.5    Spain
                      8.2.1.6    Rest of Europe
           8.2.2    By Type
           8.2.3    By End-Users
           8.2.4    Countries & Segments - Market Attractiveness Analysis
8.3    Asia Pacific
           8.3.1    By Country
                      8.3.1.1    China
                      8.3.1.2    Japan
                      8.3.1.3    South Korea
                      8.3.1.4    India      
                      8.3.1.5    Australia & New Zealand
                      8.3.1.6    Rest of Asia-Pacific
           8.3.2    By Type
           8.3.3    By End-Users
           8.3.4    Countries & Segments - Market Attractiveness Analysis
8.4    South America
           8.4.1    By Country
                      8.4.1.1    Brazil
                      8.4.1.2    Argentina
                      8.4.1.3    Colombia
                      8.4.1.4    Chile
                      8.4.1.5    Rest of South America
           8.4.2    By Type
           8.4.3    By End-Users
           8.4.4    Countries & Segments - Market Attractiveness Analysis
8.5    Middle East & Africa
           8.5.1    By Country
                      8.5.1.1    United Arab Emirates (UAE)
                      8.5.1.2    Saudi Arabia
                      8.5.1.3    Qatar
                      8.5.1.4    Israel
                      8.5.1.5    South Africa
                      8.5.1.6    Nigeria
                      8.5.1.7    Kenya
                      8.5.1.8    Egypt
                      8.5.1.9    Rest of MEA
           8.5.2    By Type
           8.5.3    By End-Users
           8.5.4    Countries & Segments - Market Attractiveness Analysis 
Chapter 9. Medical Informatics for Auto-immune Diseases Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
9.1    IBM Watson Health
9.2    Philips Healthcare
9.3    Siemens Healthineers
9.4    Cerner Corporation
9.5    Epic Systems Corporation
9.6    McKesson Corporation
9.7    Allscripts Healthcare Solutions
9.8    GE Healthcare
9.9    Change Healthcare
9.10    Health Catalyst